Oncotelic Therapeutics announced that Chief Business Officer Saran Saund will deliver a keynote at the 22nd Drug Discovery Strategic Summit on October 22, 2026, focusing on AI-enabled drug discovery through partition and aggregation. This approach breaks down complex research questions into smaller parts for parallel investigation, then combines findings to form testable hypotheses, enhancing efficiency and insight in drug research. The keynote will also highlight Oncotelic's proprietary PDAOAI platform, its intellectual property strategy, and tools like Fastbot/Membot that allow individual researchers to access the platform. This signals Oncotelic's commitment to advancing AI-driven drug discovery and expanding its technology to genetic and protein research at a large scale.
Oncotelic Therapeutics' keynote on AI-enabled drug discovery provides context for health sector market activity. As of Oct 20, 2026 19:03 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 81 rose and 62 fell. Notable movers include CTXR at USD 0.45 with a +5.19% change and a typical hold time of 18 days, XRAY at USD 8.84 up +4.99%, and ENVB at USD 1.34 down -4.96% with 100% sell order activity. The most notable figure is CTXR's 69% buy order activity on Pluang.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
